Xtx Topco LTD Cel Sci Corp Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Cel Sci Corp stock. As of the latest transaction made, Xtx Topco LTD holds 16,321 shares of CVM stock, worth $19,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,321

Holding current value

$19,748

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.63 - $3.08 $26,603 - $50,268	16,321 New	16,321 $31,000
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $37,345 - $72,230	-14,475 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.93 - $7.7 $56,886 - $111,457	14,475 New	14,475 $57,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.5M

Call Options Held

61.8K

Put Options Held

141K

Vanguard Group Inc Valley Forge, PA

2.19M
Shares

$2.65 Million
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

879K
Shares

$1.06 Million
12.54% of portfolio
Black Rock Inc. New York, NY

763K
Shares

$923,766
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

669K
Shares

$809,476
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

464K
Shares

$561,934
0.0% of portfolio

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $52.5M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account